US5206018A
(en)
*
|
1978-11-03 |
1993-04-27 |
Ayerst, Mckenna & Harrison, Inc. |
Use of rapamycin in treatment of tumors
|
US5221670A
(en)
*
|
1990-09-19 |
1993-06-22 |
American Home Products Corporation |
Rapamycin esters
|
US5358944A
(en)
*
|
1990-09-19 |
1994-10-25 |
American Home Products Corporation |
Rapamycin esters for treating transplantation rejection
|
US5378696A
(en)
*
|
1990-09-19 |
1995-01-03 |
American Home Products Corporation |
Rapamycin esters
|
US5321009A
(en)
*
|
1991-04-03 |
1994-06-14 |
American Home Products Corporation |
Method of treating diabetes
|
US5194447A
(en)
*
|
1992-02-18 |
1993-03-16 |
American Home Products Corporation |
Sulfonylcarbamates of rapamycin
|
US5286730A
(en)
*
|
1991-09-17 |
1994-02-15 |
American Home Products Corporation |
Method of treating immunoinflammatory disease
|
US5286731A
(en)
*
|
1991-09-17 |
1994-02-15 |
American Home Products Corporation |
Method of treating immunoinflammatory bowel disease
|
US5164399A
(en)
*
|
1991-11-18 |
1992-11-17 |
American Home Products Corporation |
Rapamycin pyrazoles
|
US5516781A
(en)
*
|
1992-01-09 |
1996-05-14 |
American Home Products Corporation |
Method of treating restenosis with rapamycin
|
US5262424A
(en)
*
|
1992-02-18 |
1993-11-16 |
American Home Products Corporation |
Composition of sulfonylcarbamates of rapamycin and method of treating diseases requiring immunosuppression therewith
|
US5177203A
(en)
*
|
1992-03-05 |
1993-01-05 |
American Home Products Corporation |
Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
|
DK0562853T3
(da)
|
1992-03-27 |
1996-07-01 |
American Home Prod |
29-Demethoxyrapamycin til fremkaldelse af immunsuppression
|
US5288711A
(en)
*
|
1992-04-28 |
1994-02-22 |
American Home Products Corporation |
Method of treating hyperproliferative vascular disease
|
US5256790A
(en)
*
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
CA2106034A1
(en)
*
|
1992-09-24 |
1994-03-25 |
Ralph J. Russo |
21-norrapamycin
|
US5434260A
(en)
*
|
1992-10-13 |
1995-07-18 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5489680A
(en)
*
|
1992-10-13 |
1996-02-06 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5480989A
(en)
*
|
1992-10-13 |
1996-01-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5302584A
(en)
*
|
1992-10-13 |
1994-04-12 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5480988A
(en)
*
|
1992-10-13 |
1996-01-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5262423A
(en)
*
|
1992-10-29 |
1993-11-16 |
American Home Products Corporation |
Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
|
US5260300A
(en)
*
|
1992-11-19 |
1993-11-09 |
American Home Products Corporation |
Rapamycin carbonate esters as immuno-suppressant agents
|
US5349060A
(en)
*
|
1993-01-07 |
1994-09-20 |
American Home Products Corporation |
Rapamycin 31-ester with N,N-dimethylglycine derivatives useful as immunosuppressive agents
|
US5252579A
(en)
*
|
1993-02-16 |
1993-10-12 |
American Home Products Corporation |
Macrocyclic immunomodulators
|
US7279561B1
(en)
|
1993-04-23 |
2007-10-09 |
Wyeth |
Anti-rapamycin monoclonal antibodies
|
WO1994025022A1
(en)
|
1993-04-23 |
1994-11-10 |
Abbott Laboratories |
Rapamycin conjugates and antibodies
|
US5504091A
(en)
*
|
1993-04-23 |
1996-04-02 |
American Home Products Corporation |
Biotin esters of rapamycin
|
US5387680A
(en)
*
|
1993-08-10 |
1995-02-07 |
American Home Products Corporation |
C-22 ring stabilized rapamycin derivatives
|
US5516770A
(en)
*
|
1993-09-30 |
1996-05-14 |
American Home Products Corporation |
Rapamycin formulation for IV injection
|
US5536729A
(en)
*
|
1993-09-30 |
1996-07-16 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
IL111004A
(en)
*
|
1993-09-30 |
1998-06-15 |
American Home Prod |
Oral formulations of rapamycin
|
US5616588A
(en)
*
|
1993-09-30 |
1997-04-01 |
American Home Products Corporation |
Rapamycin formulation for IV injection
|
US5373014A
(en)
*
|
1993-10-08 |
1994-12-13 |
American Home Products Corporation |
Rapamycin oximes
|
US5378836A
(en)
*
|
1993-10-08 |
1995-01-03 |
American Home Products Corporation |
Rapamycin oximes and hydrazones
|
US5391730A
(en)
*
|
1993-10-08 |
1995-02-21 |
American Home Products Corporation |
Phosphorylcarbamates of rapamycin and oxime derivatives thereof
|
US5385908A
(en)
*
|
1993-11-22 |
1995-01-31 |
American Home Products Corporation |
Hindered esters of rapamycin
|
US5385909A
(en)
*
|
1993-11-22 |
1995-01-31 |
American Home Products Corporation |
Heterocyclic esters of rapamycin
|
US5385910A
(en)
*
|
1993-11-22 |
1995-01-31 |
American Home Products Corporation |
Gem-distributed esters of rapamycin
|
US5389639A
(en)
*
|
1993-12-29 |
1995-02-14 |
American Home Products Company |
Amino alkanoic esters of rapamycin
|
US5525610A
(en)
*
|
1994-03-31 |
1996-06-11 |
American Home Products Corporation |
42-Epi-rapamycin and pharmaceutical compositions thereof
|
US5362718A
(en)
|
1994-04-18 |
1994-11-08 |
American Home Products Corporation |
Rapamycin hydroxyesters
|
US5463048A
(en)
*
|
1994-06-14 |
1995-10-31 |
American Home Products Corporation |
Rapamycin amidino carbamates
|
US5491231A
(en)
*
|
1994-11-28 |
1996-02-13 |
American Home Products Corporation |
Hindered N-oxide esters of rapamycin
|
US5563145A
(en)
*
|
1994-12-07 |
1996-10-08 |
American Home Products Corporation |
Rapamycin 42-oximes and hydroxylamines
|
US5561138A
(en)
*
|
1994-12-13 |
1996-10-01 |
American Home Products Corporation |
Method of treating anemia
|
US5496832A
(en)
*
|
1995-03-09 |
1996-03-05 |
American Home Products Corporation |
Method of treating cardiac inflammatory disease
|
US5780462A
(en)
*
|
1995-12-27 |
1998-07-14 |
American Home Products Corporation |
Water soluble rapamycin esters
|
US5922730A
(en)
*
|
1996-09-09 |
1999-07-13 |
American Home Products Corporation |
Alkylated rapamycin derivatives
|
IT1289815B1
(it)
*
|
1996-12-30 |
1998-10-16 |
Sorin Biomedica Cardio Spa |
Stent per angioplastica e relativo procedimento di produzione
|
KR20010031363A
(ko)
*
|
1997-10-22 |
2001-04-16 |
젠스 포니카우 |
진균류에 의한 점막염을 국소 치료하기 위한 항진균제의용도
|
US6015809A
(en)
*
|
1998-08-17 |
2000-01-18 |
American Home Products Corporation |
Photocyclized rapamycin
|
US6331547B1
(en)
|
1999-08-18 |
2001-12-18 |
American Home Products Corporation |
Water soluble SDZ RAD esters
|
US6670355B2
(en)
|
2000-06-16 |
2003-12-30 |
Wyeth |
Method of treating cardiovascular disease
|
DK1319008T3
(da)
|
2000-09-19 |
2009-02-09 |
Wyeth Corp |
Vandoplöselige rapamycinestere
|
US6399625B1
(en)
|
2000-09-27 |
2002-06-04 |
Wyeth |
1-oxorapamycins
|
US6399626B1
(en)
|
2000-10-02 |
2002-06-04 |
Wyeth |
Hydroxyesters of 7-desmethylrapamycin
|
US6440991B1
(en)
|
2000-10-02 |
2002-08-27 |
Wyeth |
Ethers of 7-desmethlrapamycin
|
US6923927B2
(en)
*
|
2000-10-03 |
2005-08-02 |
Atrium Medical Corporation |
Method for forming expandable polymers having drugs or agents included therewith
|
TWI286074B
(en)
|
2000-11-15 |
2007-09-01 |
Wyeth Corp |
Pharmaceutical composition containing CCI-779 as an antineoplastic agent
|
TWI233359B
(en)
*
|
2001-04-06 |
2005-06-01 |
Wyeth Corp |
Pharmaceutical composition for treating neoplasm
|
TWI296196B
(en)
*
|
2001-04-06 |
2008-05-01 |
Wyeth Corp |
Antineoplastic combinations
|
US20020198137A1
(en)
*
|
2001-06-01 |
2002-12-26 |
Wyeth |
Antineoplastic combinations
|
UA77200C2
(en)
|
2001-08-07 |
2006-11-15 |
Wyeth Corp |
Antineoplastic combination of cci-779 and bkb-569
|
US6680330B2
(en)
|
2001-08-22 |
2004-01-20 |
Wyeth |
Rapamycin dialdehydes
|
WO2003018573A1
(en)
|
2001-08-22 |
2003-03-06 |
Wyeth |
Rapamycin 29-enols
|
AU2002352726A1
(en)
|
2001-11-15 |
2003-06-10 |
Galileo Laboratories, Inc. |
Formulations and methods for treatment or amelioration of inflammatory conditions
|
CN100402031C
(zh)
|
2002-07-30 |
2008-07-16 |
惠氏公司 |
含有瑞帕霉素羟基酯的胃肠外制剂
|
DE60324609D1
(de)
*
|
2002-09-17 |
2008-12-18 |
Wyeth Corp |
GRANULIERTE FORMULIERUNG DES RAPAMYCINESTERS CCl-779
|
AR042938A1
(es)
*
|
2003-02-06 |
2005-07-06 |
Wyeth Corp |
Uso del cci-779 en el tratamiento de la fibrosis hepatica
|
UA83484C2
(uk)
*
|
2003-03-05 |
2008-07-25 |
Уайт |
Спосіб лікування раку грудей комбінацією похідного рапаміцину і інгібітора ароматази - летрозолу, фармацевтична композиція
|
KR20060006058A
(ko)
*
|
2003-04-22 |
2006-01-18 |
와이어쓰 |
항신생물성 배합물
|
US20040236410A1
(en)
*
|
2003-05-22 |
2004-11-25 |
Atrium Medical Corp. |
Polymeric body formation
|
US20040236279A1
(en)
*
|
2003-05-22 |
2004-11-25 |
Atrium Medical Corp. |
Gaseous therapeutic agent delivery
|
US20040236278A1
(en)
*
|
2003-05-22 |
2004-11-25 |
Atrium Medical Corp. |
Therapeutic agent delivery
|
US20040253185A1
(en)
*
|
2003-06-12 |
2004-12-16 |
Atrium Medical Corp. |
Medicated ink
|
AU2005238432A1
(en)
*
|
2004-04-14 |
2005-11-10 |
Wyeth |
Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
|
EP1768662A2
(de)
|
2004-06-24 |
2007-04-04 |
Novartis Vaccines and Diagnostics, Inc. |
Immunstimulatoren kleiner moleküle und assays für deren nachweis
|
KR20070083941A
(ko)
*
|
2004-10-04 |
2007-08-24 |
큐엘티 유에스에이, 인코포레이티드 |
중합체 전달 조성을 갖는 눈 전달
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
EP1962839A4
(de)
|
2005-11-14 |
2010-08-25 |
Ariad Pharma Inc |
Verabreichung von mntor-inhibitoren zur behandlung von krebspatienten
|
US20100081681A1
(en)
*
|
2006-08-16 |
2010-04-01 |
Blagosklonny Mikhail V |
Methods and compositions for preventing or treating age-related diseases
|
RU2491934C2
(ru)
*
|
2006-08-22 |
2013-09-10 |
Новартис Аг |
Лечение фиброзирующих нарушений
|
US7867988B2
(en)
|
2006-09-13 |
2011-01-11 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
US20080175887A1
(en)
*
|
2006-11-20 |
2008-07-24 |
Lixiao Wang |
Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
|
WO2008063581A2
(en)
*
|
2006-11-20 |
2008-05-29 |
Lutonix, Inc. |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
US8998846B2
(en)
|
2006-11-20 |
2015-04-07 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US9737640B2
(en)
|
2006-11-20 |
2017-08-22 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8414526B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
|
US8425459B2
(en)
|
2006-11-20 |
2013-04-23 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
|
US9700704B2
(en)
|
2006-11-20 |
2017-07-11 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US8414525B2
(en)
*
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8414910B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US20080276935A1
(en)
|
2006-11-20 |
2008-11-13 |
Lixiao Wang |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
JP2011523401A
(ja)
*
|
2008-04-29 |
2011-08-11 |
ワイス・エルエルシー |
炎症を治療するための方法
|
WO2010024898A2
(en)
|
2008-08-29 |
2010-03-04 |
Lutonix, Inc. |
Methods and apparatuses for coating balloon catheters
|
US20120064143A1
(en)
|
2008-11-11 |
2012-03-15 |
The Board Of Regents Of The University Of Texas System |
Inhibition of mammalian target of rapamycin
|
CN104997774A
(zh)
|
2009-04-10 |
2015-10-28 |
齐海燕 |
新的抗衰老试剂及其鉴别方法
|
US9283211B1
(en)
|
2009-11-11 |
2016-03-15 |
Rapamycin Holdings, Llc |
Oral rapamycin preparation and use for stomatitis
|
EP2906214A1
(de)
|
2012-10-12 |
2015-08-19 |
The Board of Regents of The University of Texas System |
Verwendung von mtor-hemmern zur behandlung von vaskulären kognitiven störungen
|
WO2014160328A1
(en)
|
2013-03-13 |
2014-10-02 |
The Board Of Regents Of The University Of Texas System |
Mtor inhibitors for prevention of intestinal polyp growth
|
JP6529012B2
(ja)
|
2013-10-08 |
2019-06-12 |
エイアイ・セラピューティクス・インコーポレーテッド |
リンパ脈管筋腫症の処置のためのラパマイシン
|
AU2014373683B2
(en)
|
2013-12-31 |
2020-05-07 |
Rapamycin Holdings, Llc |
Oral rapamycin nanoparticle preparations and use
|
US9700544B2
(en)
|
2013-12-31 |
2017-07-11 |
Neal K Vail |
Oral rapamycin nanoparticle preparations
|
EP3104891A1
(de)
*
|
2014-02-11 |
2016-12-21 |
Lam Therapeutics, Inc. |
Rapamycin zur behandlung von lymphangioleiomyomatose
|
US10307371B2
(en)
|
2014-02-11 |
2019-06-04 |
AI Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
CA2944075C
(en)
|
2014-04-04 |
2022-06-28 |
Lam Therapeutics, Inc. |
An inhalable rapamycin formulation for treating age-related conditions
|
WO2016040570A2
(en)
|
2014-09-12 |
2016-03-17 |
Children's Medical Center Corporation |
Dietary emulsion formulations and methods for using the same
|
RU2732908C2
(ru)
|
2014-10-07 |
2020-09-24 |
ЭйАй ТЕРАПЬЮТИКС, ИНК. |
Ингаляционная лекарственная форма рапамицина для лечения легочной гипертензии
|
WO2016066608A1
(en)
*
|
2014-10-28 |
2016-05-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for treatment of pulmonary cell senescence and peripheral aging
|
MA40910A
(fr)
|
2014-11-07 |
2017-09-12 |
Civitas Therapeutics Inc |
Poudres de rapamycine pour administration pulmonaire
|
WO2016130645A1
(en)
|
2015-02-10 |
2016-08-18 |
Lam Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|